AlzBiomarker
Alzheimer's Disease vs Control: VLP-1 (CSF)
Meta-analysis Results: A handful of studies have quantified VLP-1 in the cerebrospinal fluid of people with Alzheimer’s disease. Meta-analysis of eight eligible studies suggests VLP-1 is significantly higher in AD patients (effect size = 1.355, p < 0.0001). Visinin-like protein 1, also known as VILIP-1, is a calcium-signaling molecule expressed in neurons.

